Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced that its board of directors will meet on March 31, 2025, to review and approve the company’s annual financial results for the year ending December 31, 2024. The board will also consider recommending a final dividend, which could impact shareholder returns and reflect the company’s financial health.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the healthcare industry. It is listed on the Hong Kong Stock Exchange and is involved in developing and commercializing ophthalmic therapies.
YTD Price Performance: 6.89%
Average Trading Volume: 2,183,894
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.95B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue